CYCN
NASDAQ · Biotechnology
Cyclerion Therapeutics Inc
$31.11
-0.06 (-0.19%)
Open$31.00
Previous Close$31.17
Day High$32.30
Day Low$30.00
52W High$59.36
52W Low$7.19
Volume—
Avg Volume175.6K
Market Cap1.55B
P/E Ratio—
EPS$-1.68
SectorBiotechnology
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 33.04M | 30.49M | 1.11M |
| Net Income | -56,195,672 | -46,674,146 | -131,808 |
| Profit Margin | -170.1% | -161.6% | -11.8% |
| EBITDA | -58,232,518 | -51,052,872 | -161,572 |
| Free Cash Flow | — | — | -153,109 |
| Rev Growth | +8.4% | +8.4% | +14.6% |
| Debt/Equity | — | — | 0.60 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |